NEW YORK (GenomeWeb News) – Clinical Data division PGxHealth today said that Aetna would provide coverage for its Familion family of genetic tests that are used for detecting inherited forms of cardiac channelopathies and cardiomyopathies.
The Newton, Mass.-based firm did not provide financial details of the reimbursement, but it noted that with the in-network coverage for Aetna patients, its Familion tests have positive reimbursement policies from private and public insurers covering an estimated 155 million lives. It also noted that PGxHealth is an approved Medicare provider for its genetic testing services and a Medicaid provider in 37 states and the District of Columbia.
The Familion tests detect genetic mutations that can cause cardiac channelopathies and cardiomyopathies, said Clinical Data. The tests can be used by physicians to help guide treatment and reduce the incidence of fatal cardiac events, the firm said.